Page last updated: 2024-08-22

gold and Epilepsy Progressive Myoclonic 2

gold has been researched along with Epilepsy Progressive Myoclonic 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gentry, MS; Li, S; Sharma, S; Simmons, ZR; Vander Kooi, CW; Wayne, J	1

Other Studies

1 other study(ies) available for gold and Epilepsy Progressive Myoclonic 2

Article	Year
Generation and characterization of a laforin nanobody inhibitor. Clinical biochemistry, 2021, Volume: 93 Topics: Animals; Biological Assay; Camelids, New World; Chromatography, Gel; Enzyme Inhibitors; Epitope Mapping; Glycogen; Gold; Humans; Hydrogen Deuterium Exchange-Mass Spectrometry; Lafora Disease; Models, Molecular; Nitrophenols; Organometallic Compounds; Organophosphorus Compounds; Phosphoric Monoester Hydrolases; Protein Binding; Protein Tyrosine Phosphatases, Non-Receptor; Single-Domain Antibodies	2021

Article

Year

Generation and characterization of a laforin nanobody inhibitor.

Clinical biochemistry, 2021, Volume: 93

Topics: Animals; Biological Assay; Camelids, New World; Chromatography, Gel; Enzyme Inhibitors; Epitope Mapping; Glycogen; Gold; Humans; Hydrogen Deuterium Exchange-Mass Spectrometry; Lafora Disease; Models, Molecular; Nitrophenols; Organometallic Compounds; Organophosphorus Compounds; Phosphoric Monoester Hydrolases; Protein Binding; Protein Tyrosine Phosphatases, Non-Receptor; Single-Domain Antibodies

2021